Steven Cohen’s Sana Biotechnology SANA Stock Holding History

Steven Cohen’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-300,000	Closed	-$489K	–	2479
2024 Q4	$489K	Buy	300,000 +100,000	+50%	+$298K	﹤0.01%	1668
2024 Q3	$832K	Buy	200,000 +90,000	+82%	+$473K	﹤0.01%	1479
2024 Q2	$601K	Buy	+110,000	New	+$877K	﹤0.01%	1395

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Steven Cohen's SANA Position: Q2 2026 in Review

Steven Cohen opened a new position in Sana Biotechnology (SANA) in Q2 2026: 595,091 shares worth $2.08M. The stake represents ﹤0.01% of the portfolio and ranks #2365 among its holdings. This is a return to the name: Steven Cohen previously reported a position in SANA as recently as Q4 2024.

Steven Cohen first reported a position in SANA in Q4 2024 and has held it in 2 quarters since. 208 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Steven Cohen held 595,091 shares of Sana Biotechnology worth $2.08M as of Q2 2026.
Sana Biotechnology was a new Steven Cohen position in Q2 2026.
Sana Biotechnology made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #2365 holding.
Steven Cohen first reported a position in Sana Biotechnology in Q4 2024 and has held it in 2 quarters since.
208 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.